Birdwatch Note Rating
2024-11-29 04:11:38 UTC - SOMEWHAT_HELPFUL
Rated by Participant: B8BB9AD3F1D35E746E5F4CAB22E62C6D70995419FF34E6E1253926FA4A1719CB
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details